Cargando…

Derivation of Naïve Human Embryonic Stem Cells Using a CHK1 Inhibitor

Embryonic development is a continuum in vivo. Transcriptional analysis can separate established human embryonic stem cells (hESC) into at least four distinct developmental pluripotent stages, two naïve and two primed, early and late relative to the intact epiblast. In this study we primarily show th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ware, Carol B., Jonlin, Erica C., Anderson, Donovan J., Cavanaugh, Christopher, Hesson, Jennifer, Sidhu, Sonia, Cook, Savannah, Villagomez-Olea, Guillermo, Horwitz, Marshall S., Wang, Yuliang, Mathieu, Julie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662141/ https://www.ncbi.nlm.nih.gov/pubmed/37702917 http://dx.doi.org/10.1007/s12015-023-10613-2

Ejemplares similares

Enhancer Chromatin and 3D Genome Architecture Changes from Naive to Primed Human Embryonic Stem Cell States
por: Battle, Stephanie L., et al.
Publicado: (2019)

The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition
por: Sperber, Henrik, et al.
Publicado: (2015)

Chk1, Chk2, is the amplifier on?
por: Dove, Alan W.
Publicado: (2001)

Informed Consent for Human Embryo Genome Editing
por: Jonlin, Erica C.
Publicado: (2020)

Fine-scale chromatin interaction maps reveal the cis-regulatory landscape of human lincRNA genes
por: Ma, Wenxiu, et al.
Publicado: (2014)

Regulation of Chk1
por: Tapia-Alveal, Claudia, et al.
Publicado: (2009)

Keeping RelApse in Chk: molecular mechanisms of Chk1 inhibitor resistance in lymphoma
por: Black, Elizabeth M., et al.
Publicado: (2022)

Regulation, targets and functions of CHK
por: Zhu, Shudong, et al.
Publicado: (2022)

Tumour growth environment modulates Chk1 signalling pathways and Chk1 inhibitor sensitivity
por: Massey, Andrew J.
Publicado: (2016)

Trial Watch: Targeting ATM–CHK2 and ATR–CHK1 pathways for anticancer therapy
por: Manic, Gwenola, et al.
Publicado: (2015)

Clinical and functional significance of CHK1-S, an alternatively spliced isoform of the CHK1 gene, in hepatocellular carcinoma
por: Hu, Guanghui, et al.
Publicado: (2020)

Ubiquitination of the DNA-damage checkpoint kinase CHK1 by TRAF4 is required for CHK1 activation
por: Yu, Xinfang, et al.
Publicado: (2020)

microRNAs Regulating Human and Mouse Naïve Pluripotency
por: Wang, Yuliang, et al.
Publicado: (2019)

Analysis of CHK2 in vulval neoplasia
por: Reddy, A, et al.
Publicado: (2002)

Chk1 suppressed cell death
por: Meuth, Mark
Publicado: (2010)

Checkmate to CHK1 in T-cell ALL?
por: Sarmento, Leonor M., et al.
Publicado: (2015)

Chk-mate on resistance to kinase inhibitors
por: Shapiro, Paul
Publicado: (2018)

Editorial: Regulation and dysfunction of CSK and CHK
por: Zhu, Shudong, et al.
Publicado: (2023)

Chk1 C-terminal regulatory phosphorylation mediates checkpoint activation via derepression of Chk1 catalytic activity
por: Walker, M, et al.
Publicado: (2009)

A novel Chk1-binding peptide that enhances genotoxic sensitivity through the cellular redistribution of nuclear Chk1
por: Kim, Kwang Seok, et al.
Publicado: (2016)

Dominant mutations in CHK1 cause pronuclear fusion failure and zygote arrest that can be rescued by CHK1 inhibitor
por: Zhang, Honghui, et al.
Publicado: (2021)

BRD7 suppresses tumor chemosensitivity to CHK1 inhibitors by inhibiting USP1-mediated deubiquitination of CHK1
por: Li, Lemin, et al.
Publicado: (2023)

The FHA domain determines Drosophila Chk2/Mnk localization to key mitotic structures and is essential for early embryonic DNA damage responses
por: Takada, Saeko, et al.
Publicado: (2015)

Targeting Chk1 in the replicative stress response
por: Dai, Yun, et al.
Publicado: (2010)

γH2AX and Chk1 phosphorylation as predictive pharmacodynamic biomarkers of Chk1 inhibitor-chemotherapy combination treatments
por: Rawlinson, Rebecca, et al.
Publicado: (2014)

Analysis of the ATR-Chk1 and ATM-Chk2 pathways in male breast cancer revealed the prognostic significance of ATR expression
por: Di Benedetto, Anna, et al.
Publicado: (2017)

AR phosphorylation and CHK2 kinase activity regulates IR-stabilized AR–CHK2 interaction and prostate cancer survival
por: Ta, Huy Q, et al.
Publicado: (2020)

Resistance to the CHK1 inhibitor prexasertib involves functionally distinct CHK1 activities in BRCA wild-type ovarian cancer
por: Nair, Jayakumar, et al.
Publicado: (2020)

CHK1 inhibition exacerbates replication stress induced by IGF blockade
por: Wu, Xiaoning, et al.
Publicado: (2021)

The Role of Wild-Type p53 in Cisplatin-Induced Chk2 Phosphorylation and the Inhibition of Platinum Resistance with a Chk2 Inhibitor
por: Liang, Xiaobing, et al.
Publicado: (2011)

Prexasertib, a Chk1/Chk2 inhibitor, increases the effectiveness of conventional therapy in B-/T- cell progenitor acute lymphoblastic leukemia
por: Rorà, Andrea Ghelli Luserna Di, et al.
Publicado: (2016)

Overexpression of TopBP1, a canonical ATR/Chk1 activator, paradoxically hinders ATR/Chk1 activation in cancer
por: Liu, Kang, et al.
Publicado: (2021)

Direct comparison of distinct naive pluripotent states in human embryonic stem cells
por: Warrier, S., et al.
Publicado: (2017)

Chk1 Haploinsufficiency Results in Anemia and Defective Erythropoiesis
por: Boles, Nathan C., et al.
Publicado: (2010)

CHK2 kinase in the DNA damage response and beyond
por: Zannini, Laura, et al.
Publicado: (2014)

Targeting the ATR-CHK1 Axis in Cancer Therapy
por: Rundle, Stuart, et al.
Publicado: (2017)

Chk1 and Wee1 kinases coordinate DNA replication, chromosome condensation, and anaphase entry
por: Fasulo, Barbara, et al.
Publicado: (2012)

Activation of mammalian Chk1 during DNA replication arrest: a role for Chk1 in the intra-S phase checkpoint monitoring replication origin firing
por: Feijoo, Carmen, et al.
Publicado: (2001)

CTP sensing and Mec1(ATR)-Rad53(CHK1/CHK2) mediate a two-layered response to inhibition of glutamine metabolism
por: Ajazi, Arta, et al.
Publicado: (2022)

CRISPR/Cas9-mediated genome editing in naïve human embryonic stem cells
por: Jacobs, Eva Z., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_id2ief2aa493u003gundbehedt